The Department of Immunology and Allergology organises and delivers study programmes at all levels: undergraduate, graduate, and doctoral. The teaching staff of the Department comprises 14 members:
- 1 professor
- 3 associate professors
- 2 assistants
- 1 junior assistant
- 7 lecturers
Integrated studies
- Course “Atsakas į aplinkos poveikį ir struktūros homeostazę” / “Response to Environmental Impact and Structural Homeostasis” (in Lithuanian and English) for the 1st year students of Medicine
- Course “Odos ir venerinės ligos, alergologija, imunologija, reumatologija” / “Dermatovenereology, Allergology, Immunology, and Rheumatology” (in Lithuanian and English), as of 2025, for the 4th year students of Medicine
- Course “Imunologija ir imunoprofilaktika” / “Immunology and Immunoprophylaxis” (in Lithuanian and English) for the 2nd year students of Pharmacy
Undergraduate courses
- Course “Imunologijos pagrindai” / “Basics of Immunology” (in Lithuanian and Engish) for the 2nd year students of Medical and Veterinary Genetics
- Course “Laboratorinė hematologija ir imunologijos pagrindai” / “Laboratory Hematology and Basics of Immunology” (in Lithuanian and English) for the 3rd year students of Medical and Veterinary Biochemistry (delivered in partnership with the Department of Laboratory Medicine).
Graduate courses
- Course “Molekulinė imunologija” / “Molecular Immunology” (in Lithuanian and English) for the students of Medicinal Chemistry.
Residency programme
- Residency programme in Allergology and Clinical Immunology (duration: 5 years):
- Aim: to provide the knowledge and skills required for specialists to diagnose and treat acute and chronic internal, immune, and allergic conditions, develop an individual treatment plan, and deliver emergency medical care.
- Programme outcomes: the programme equips residency graduates with competences aligned with the qualification requirements for allergologists and clinical immunologists.
Professional development courses
- “Allergology and Clinical Immunology”
- “Latest Developments in Immunology and Allergology”
Intended for medical doctors across different specialties
Doctoral studies
Doctoral study programmes:
- Allergology. The programme aims to systematise and deepen knowledge of increased immune sensitivity (allergy) as the most common form of immune response disorder, its mechanisms, and their role in the development, diagnosis, treatment, and prevention of allergic diseases. It also seeks to enhance the understanding of achievements and outlook in the scientific field of allergology, as well as their application in diagnosis and treatment.
- Clinical Immunology. The programme aims to systematise and deepen knowledge of normal and impaired immune responses, as well as various aspects of the pathogenesis, diagnosis, and treatment of immune diseases.
The current number of doctoral students is 3.
Our research priority focuses on multidisciplinary projects aimed at exploring new aspects of chronic disease development for better understanding of the mechanisms behind immune responses. The research works currently carried out at the Department provide the framework for the analysis of the relationship between immunological changes in allergen-induced airway inflammation and the manifestation of symptoms and clinical course, taking into account different disease phenotypes; characteristics of immune responses in malignant diseases and immunodeficiencies. This paves the way for identifying new markers and molecules which play significant role in the development of diseases. The knowledge gained in the process helps close the gaps in the understanding of pathogenesis of various diseases and expands the horizons when exploring new diagnostic and treatment possibilities.
Research conducted by allergologists and clinical immunologists is published in high-impact journals indexed in the core collection journals of the Institute for Scientific Information (ISI), including American Journal of Respiratory Cellular and Molecular Biology, Journal of Allergy and Clinical Immunology, The New England Jornal of Medicine, Journal of Investigational Allergology and Clinical Immunology, among others. The results of research activities are presented annually at the congresses and assemblies of the European Academy of Allergy and Clinical Immunology (EAACI), the Clinical Allergy and Immunology Assembly of the European Respiratory Society (ERS), as well as at the congresses of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the World Allergy Organization (WAO).
Applied clinical research is conducted in accordance with Good Clinical Practice guidelines. Ongoing clinical studies:
- “A prospective, multicentre, long-term study to evaluate the safety and efficacy of nemolizumab (CD14152) in subjects with moderate-to-severe atopic dermatitis”
- “A randomised, parallel-group, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of a five-grass pollen mixture sublingual immunotherapy (SLIT) drops in adult patients with grass pollen-induced rhinoconjunctivitis”
- “Inclusion of patients with primary immunodeficiency treated at the Centre of Primary Immunodeficiency of LSMU Hospital Kauno Klinikos in the European Society for Immunodeficiencies (ESID) Registry”
- “A retrospective observational study evaluating the burden of disease and treatment in patients with hereditary angioedema types I and II (Protocol TAK-743-4009)”
- “A randomised, double-blind, placebo-controlled, multicentre study evaluating the efficacy of subcutaneous immunotherapy with the ‘PURETHAL Mites’ mixture (50,000 AUeq/ml) in adults with moderate-to-severe allergic rhinitis/rhinoconjunctivitis, with or without asthma, induced by house dust mites”
Since 2022, a joint research project involving Lithuania, Latvia, and China (Taiwan) has been implemented and completed: “A comparative study of vitamin D and vitamin D receptor gene polymorphisms among children and adults with atopic dermatitis and asthma in Lithuania, Latvia, and Taiwan” (Reg. No. P-LLT-20-4; duration: 3 years)
At the initiative of allergologists and clinical immunologists, since 2005 LSMU has served as a collaborating centre of the European Union’s Sixth Framework Programme project GA²LEN (Global Allergy and Asthma European Network.
The Department hosts the Centre of Primary Immunodeficiency, which is a member of the international Jeffrey Modell Foundation since 2012 and of the J Project since 2016.
The links and long-standing collaboration established with the European research centres and active participation in international organisations contribute to not only the acquisition of new knowledge in allergology and immunology, but also the implementation of the latest diagnostic and treatment methods for allergic and immune diseases, the advancement of teaching content and practices, and the further development of research. These activities also provide a foundation for continued successful advancement of this field of medicine.